RE: BOD the issue31 Dec 2020 01:12
RE consultancy fees
"Further, the Company advises that, in relation to Funding Agreement announced on 14 December 2020, the Company has issued 42,500,000 warrants in relation to advisory fees. These warrants are valid for 3 years from the date of grant and with an exercise price of 2 pence per share. If exercised, these warrants would result in gross proceeds being received by the Company of approximately £850,000."